Home

Brenk lab

Professor Ruth Brenk

The overall research goal of the Brenk lab is to improve methods used for structure-based drug design and to apply these methods to design inhibitors for enzymes with biological relevance. A key point in our research is the interplay of theoretical and experimental methods.

For more details, check out our research page.

New paper
TOC graphic - Biomolecules

Virtual screening for beta-lactamase inhibitors

Another paper from the Brenk group published.

Price winner
Illimar Rekand

Price for oral presentation

Congratulations to Illimar who got the price for the second best oral presentation at the 34. Molecular Modeling Workshop 2020 in Erlangen. Well done!

NFR INFRA call poroposal rejected.
no new equipment

Full scores but no funding

The Nor-Openscreen application for this year's infrastructure call scored the highest possible marks in all categories! To quote from the reviewer comments: "This is an excellent proposal to enlarge and update existing infrastructure and services in chemical biology in Norway"....

Webinar

Structure-based design of riboswitch and kinase ligands

A webinar about structure-based design of riboswitch and kinase ligands.

We offer topics for the degree MSc in the area of structure-based drug design, e.g. molecular modelling, fragment screening and X-ray crystallography. Don't hestitate to contact us for chat to discuss what exactly we can offer and how we can tailor this to match your  interests.

The Brenk Lab is part of the Biorecognition Research Group.